Ah yeah, that's right. Any confirmatory trial should be able to be designed to focus, laser like, on those aspects of the disease and type of patients that stand to benefit the most. Ideally, that's the ticket for a nice fat partnership.
Phase 3 DREAM HF-1 read-out, page-27
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.060(5.33%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $7.935M | 7.229M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 62660 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 86301 | 20 |
View Market Depth
| Last trade - 15.48pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |